Jefferson Capital, Inc. (JCAP)

NASDAQ: JCAP · Real-Time Price · USD

18.36

+0.78 (4.44%)

At close: Aug 13, 2025, 4:00 PM

18.01

-0.35 (-1.91%)

After-hours: Aug 13, 2025, 4:47 PM EDT

G1 Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Net Income	160.22	128.89	111.52
Depreciation & Amortization	8.06	6.86	5.28
Provision & Write-off of Bad Debts	3.25	3.5	3.52
Other Operating Activities	7.74	7.74	0.02
Change in Accounts Payable	18.12	28.98	8.24
Change in Other Net Operating Assets	-12.9	-7.76	-8.37
Operating Cash Flow	184.49	168.21	120.22
Operating Cash Flow Growth	-	39.92%	-
Capital Expenditures	-6.2	-6.21	-1.23
Cash Acquisitions	-	-	-5.6
Other Investing Activities	-525.75	-534.58	-393.47
Investing Cash Flow	-533.12	-542.37	-403.41
Short-Term Debt Issued	-	1,082	654.73
Total Debt Issued	792.57	1,082	654.73
Short-Term Debt Repaid	-	-650.4	-328.41
Total Debt Repaid	-376.56	-650.4	-328.41
Net Debt Issued (Repaid)	416	432.09	326.32
Common Dividends Paid	-52	-36	-30.56
Other Financing Activities	-0.83	-7.27	-5.9
Financing Cash Flow	363.18	388.82	289.86
Foreign Exchange Rate Adjustments	1.83	2.98	-1.22
Net Cash Flow	16.38	17.64	5.45
Free Cash Flow	178.3	162	118.99
Free Cash Flow Growth	-	36.14%	-
Free Cash Flow Margin	36.76%	37.35%	35.41%
Cash Interest Paid	80.49	58.13	45.11
Cash Income Tax Paid	9.43	8.67	9.05
Levered Free Cash Flow	-	-378.07	-
Unlevered Free Cash Flow	-	-329.79	-
Change in Working Capital	5.23	21.22	-0.13

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q